Top

Clinical and Translational Oncology

Published in:

01-02-2007 | RESEARCH ARTICLES

Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine

Authors: I. Maestu, J. Muñoz, L. Gómez-Aldaraví, G. Esquerdo, A. Yubero, M. D. Torregrosa, R. Romero

Published in: Clinical and Translational Oncology | Issue 2/2007

Title: Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine
Authors: I. Maestu
J. Muñoz
L. Gómez-Aldaraví
G. Esquerdo
A. Yubero
M. D. Torregrosa
R. Romero
Publication date: 01-02-2007
Publisher: Springer-Verlag
Published in: Clinical and Translational Oncology / Issue 2/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-007-0019-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 2/2007

Dendritic cells: still a promising tool for cancer immunotherapy

Blindness in a bladder cancer patient

Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab

Risk factors of local relapse in breast cancer: the importance of age

The issue of nutrition and cancer

Surgical teaching can improve oncological outcomes: the rectal cancer experience

Keynote webinar | Spotlight on antibody–drug conjugates in cancer